secwatch.observer — SEC 8-K summary
======================================

Issuer:     EyePoint, Inc. (EYPT)
CIK:        0001314102
Form:       8-K
Filed at:   2026-07-17T20:05:14+00:00
Accession:  0001193125-26-307792
Event type: litigation
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EyePoint settles DOJ False Claims Act probe for $4.68M; enters 5-year CIA
-------------------------------------------------------------------------

- Settlement payment of $4,678,981.86 plus 4.25% interest from Jan 28, 2026, due within 14 days.
- No admission of liability; DOJ releases civil claims related to DEXYCU marketing (kickbacks, sampling).
- 5-year Corporate Integrity Agreement with OIG-HHS requires compliance officer, board oversight, independent review.
- Company also pays $166,500 in relator's attorney fees within 60 days.
- DEXYCU commercialization ended in 2023; company will use cash on hand for payments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314102/000119312526307792/0001193125-26-307792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314102/000119312526307792/eypt-20260713.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-307792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer